Group One Trading
EBS icon

Group One Trading’s Emergent Biosolutions EBS Stock Holding History

Group One Trading’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$675K Sell
81,300
-1,400
-2% -$14.5K ﹤0.01% 3063
2025
Q4 		$1.02M Sell
82,700
-5,100
-6% -$54.6K ﹤0.01% 2868
2025
Q3 		$774K Buy
87,800
+14,900
+20% +$116K ﹤0.01% 3274
2025
Q2 		$465K Sell
72,900
-21,300
-23% -$122K ﹤0.01% 3493
2025
Q1 		$458K Buy
94,200
+5,300
+6% +$43.9K ﹤0.01% 3182
2024
Q4 		$850K Sell
88,900
-184,900
-68% -$1.7M ﹤0.01% 2724
2024
Q3 		$2.29M Buy
273,800
+29,500
+12% +$268K 0.01% 1623
2024
Q2 		$1.67M Sell
244,300
-104,000
-30% -$448K 0.01% 1599
2024
Q1 		$881K Buy
348,300
+254,100
+270% +$573K ﹤0.01% 2206
2023
Q4 		$226K Buy
94,200
+80,500
+588% +$189K ﹤0.01% 3766
2023
Q3 		$46.6K Sell
13,700
-10,900
-44% -$60.4K ﹤0.01% 5164
2023
Q2 		$181K Sell
24,600
-9,900
-29% -$91.8K ﹤0.01% 4047
2023
Q1 		$357K Buy
+34,500
New +$417K ﹤0.01% 3092
2022
Q4 		– Sell
-500
Closed -$11K – 7430
2022
Q3 		$11K Sell
500
-15,800
-97% -$440K ﹤0.01% 6427
2022
Q2 		$506K Buy
16,300
+5,800
+55% +$198K ﹤0.01% 3412
2022
Q1 		$431K Sell
10,500
-13,100
-56% -$578K ﹤0.01% 3983
2021
Q4 		$1.03M Buy
23,600
+2,800
+13% +$127K ﹤0.01% 3336
2021
Q3 		$1.04M Buy
20,800
+600
+3% +$36.3K ﹤0.01% 3370
2021
Q2 		$1.27M Buy
20,200
+4,500
+29% +$289K ﹤0.01% 3127
2021
Q1 		$1.46M Sell
15,700
-12,600
-45% -$1.29M ﹤0.01% 2796
2020
Q4 		$2.54M Buy
28,300
+16,500
+140% +$1.51M ﹤0.01% 1857
2020
Q3 		$1.22M Buy
11,800
+800
+7% +$86.2K ﹤0.01% 2018
2020
Q2 		$870K Buy
+11,000
New +$820K ﹤0.01% 2159
2017
Q4 		– Sell
-5,000
Closed -$202K – 4916
2017
Q3 		$202K Hold
5,000
– – ﹤0.01% 2749
2017
Q2 		$170K Buy
+5,000
New +$154K ﹤0.01% 2762

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Group One Trading's EBS Position: Q1 2026 in Review

Group One Trading increased its Emergent Biosolutions (EBS) stake by 158% in Q1 2026, buying an estimated $115K and bringing the position to 18,149 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #4355.

Group One Trading first reported a position in EBS in Q2 2016 and has held it in 25 quarters since. The position peaked at $2.84M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Group One Trading held 18,149 shares of Emergent Biosolutions worth $151K as of Q1 2026.
  • Group One Trading bought 11,109 Emergent Biosolutions shares in Q1 2026, an estimated $115K.
  • Emergent Biosolutions made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4355 holding.
  • Group One Trading first reported a position in Emergent Biosolutions in Q2 2016 and has held it in 25 quarters since.
  • Group One Trading's Emergent Biosolutions position peaked at $2.84M in Q3 2020.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.